Yasui M - Search Results

1

Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era.

Shimada H, Tanizawa A, Kondo T, Nagamura-Inoue T, Yasui M, Tojo A, Muramatsu H, Eto T, Doki N, Tanaka M, Sato M, Noguchi M, Uchida N, Takahashi Y, Sakata N, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Ohashi K; Pediatric and Adult CML/MPN Working Groups of the Japanese Society for Transplantation and Cellular Therapy. Shimada H, et al. Among authors: yasui m. Transplant Cell Ther. 2022 Jul;28(7):376-389. doi: 10.1016/j.jtct.2022.04.011. Epub 2022 Apr 18. Transplant Cell Ther. 2022. PMID: 35447373 Free article.

2

Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.

Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, Kimoto T, Yamada K, Tokimasa S, Yasui M, Inoue M. Kawa K, et al. Among authors: yasui m. Bone Marrow Transplant. 2011 Jan;46(1):77-83. doi: 10.1038/bmt.2010.122. Epub 2010 May 24. Bone Marrow Transplant. 2011. PMID: 20498651

3

Pneumococcal arthritis affects performance status in patients with chronic GVHD of the skin following allogeneic bone marrow transplantation.

Sakata N, Yasui M, Kawa K. Sakata N, et al. Among authors: yasui m. Int J Hematol. 2001 Jul;74(1):90-4. doi: 10.1007/BF02982556. Int J Hematol. 2001. PMID: 11530813 Review.

4

Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease.

Sakata N, Yasui M, Okamura T, Inoue M, Yumura-Yagi K, Kawa K. Sakata N, et al. Among authors: yasui m. Bone Marrow Transplant. 2001 Jun;27(11):1153-61. doi: 10.1038/sj.bmt.1703060. Bone Marrow Transplant. 2001. PMID: 11551026

5

Feasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia.

Yamada K, Yasui M, Kondo O, Sato M, Sawada A, Kawa K, Inoue M. Yamada K, et al. Among authors: yasui m. Pediatr Blood Cancer. 2013 Aug;60(8):E60-2. doi: 10.1002/pbc.24507. Epub 2013 Mar 6. Pediatr Blood Cancer. 2013. PMID: 23468187 Clinical Trial.

6

[Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].

Sakata N, Sato E, Sawada A, Yasui M, Inoue M, Kawa K. Sakata N, et al. Among authors: yasui m. Rinsho Ketsueki. 2004 May;45(5):393-6. Rinsho Ketsueki. 2004. PMID: 15199749 Japanese.

7

Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse After Haploidentical Hematopoietic Stem Cell Transplantation.

Mayumi A, Sawada A, Ioi A, Higuchi K, Shimizu M, Sato M, Yasui M, Inoue M. Mayumi A, et al. Among authors: yasui m. J Pediatr Hematol Oncol. 2018 Mar;40(2):e129-e132. doi: 10.1097/MPH.0000000000000937. J Pediatr Hematol Oncol. 2018. PMID: 28816796

8

High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS).

Fujino H, Ishida H, Iguchi A, Onuma M, Kato K, Shimizu M, Yasui M, Fujisaki H, Hamamoto K, Washio K, Sakaguchi H, Miyashita E, Osugi Y, Nakagami-Yamaguchi E, Hayakawa A, Sato A, Takahashi Y, Horibe K. Fujino H, et al. Among authors: yasui m. Int J Hematol. 2019 May;109(5):578-583. doi: 10.1007/s12185-019-02627-9. Epub 2019 Mar 12. Int J Hematol. 2019. PMID: 30864117

9

Impact of melphalan dose during reduced-intensity conditioning on engraftment of cord blood transplantation for chronic Epstein-Barr virus-associated T or NK cell lymphoproliferative diseases.

Mayumi A, Sawada A, Sato M, Shimizu M, Ioi A, Higuchi K, Yasui M, Kawa K, Inoue M. Mayumi A, et al. Among authors: yasui m. Pediatr Blood Cancer. 2020 Sep;67(9):e28536. doi: 10.1002/pbc.28536. Epub 2020 Jun 21. Pediatr Blood Cancer. 2020. PMID: 32564520

10

HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis.

Higuchi K, Sawada A, Kondo O, Okada Y, Tsujimoto H, Ioi A, Mayumi A, Shimizu M, Sato M, Goto K, Inoue S, Yasui M, Inoue M. Higuchi K, et al. Among authors: yasui m. Int J Hematol. 2022 Mar;115(3):406-413. doi: 10.1007/s12185-021-03270-z. Epub 2022 Jan 14. Int J Hematol. 2022. PMID: 35028882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

901 results

Search Page